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Abstract
Gender-based heterogeneity in periodontal disease has been witnessed in the 
recent past with huge mounting evidence. The composite effect of sex-based genetic 
structure and the sex steroid hormones runs in line with the corresponding gender-
related differences in risk for chronic periodontitis. Since estrogens, the predomi-
nant sex hormones in women, show immune protective and anti-inflammatory 
effects in hormonally active premenopausal women, they show better periodontal 
status compared to age-matched men. Conversely, after menopause with a weaken-
ing estrogen signal, women may show an equal or even more serious periodontal 
status compared to men. Periodontal status of postmenopausal women may be 
improved by menopausal hormone therapy. Alveolar bone loss, an irreversible sign 
of past periodontal disease activity can be easily observed on radiographs in an 
objective manner. Orthopantomographs provide a fairly accurate assessment of the 
status of alveolar bone in the whole mouth. A cross-sectional retrospective pan-
oramic radiographic analysis has been carried out in a north Indian dental institute 
to decipher the gender-based distribution of periodontal bone loss. The current 
chapter shall provide an update on gender-based differences in oral health, underly-
ing mechanisms, differences in patterns and distribution of alveolar bone loss (case 
study), and potential gender-specific disease protection and management strategies.
Keywords: oral health, periodontal, gender, alveolar bone loss, radiography, 
panoramic
1. Introduction
Many human diseases, specifically chronic immune-mediated diseases, 
present differentially in males and females [1]. Differential gene expression and 
immune system in the human body guided by sex steroid hormones are respon-
sible for the differential physiologic constitution of the two genders [2]. Chronic 
periodontal disease is an immune-inflammatory disorder affecting teeth and 
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supporting tissues, inducing the destruction of alveolar bone, and ultimately 
leading to loss of teeth if it remains untreated. As evidence of periodontal infec-
tion’s influence on overall chronic inflammatory disease states of human body 
continues to mount from last two decades, a whole new concept of the status 
of the oral cavity and its impact on systemic health and disease has evolved. 
Immense research efforts have been directed toward better understanding of the 
prevention and control of human periodontal diseases that have been warranted 
in the recent past [3].
Enhanced understanding regarding the causation mechanisms of human 
periodontal disease in the recent past and the identification and recognition of the 
potential significant susceptibility factors, which are a part of the causal chain for 
initiation and progression of periodontal disease, have led to focused research into 
specific risk factors for periodontal disease. Greater age [4–8], male sex [9, 10], 
bacterial plaque [4, 8], and smoking [8, 11–13] have been linked with an increased 
susceptibility to periodontal disease [14].
Epidemiological investigations have explored the role of these risk factors for 
periodontal disease causation and treatment needs of populations. A risk factor may 
be anything like environmental exposure, a behavioral aspect, or a constitutional 
feature which may enhance the chances of occurrence of disease. The term “deter-
minant” is generally used interchangeably with risk factors, but it is more appropri-
ate to limit its usage for the risk factors that cannot be modified, for example, age 
and sex. Readers are referred to go through many elaborate and exhaustive reviews 
on these particular aspects to enhance their understanding regarding differential 
risk and risk factors of periodontal diseases [15]. The current chapter shall provide 
an update specifically on gender-based differences in oral and periodontal health, 
underlying mechanisms, differences in patterns and distribution of alveolar bone 
loss (based on the case study), and potential gender-specific disease protection and 
management strategies.
2. Periodontal disease
Periodontal diseases primarily comprise the two most common oral inflamma-
tory disorders, that is, gingivitis and periodontitis, which are caused by microbes 
residing in the subgingival dental plaque. To name a few, primary pathogens like 
Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Tannerella forsythia, 
and Treponema denticola trigger an immune reaction from the host, including innate, 
inflammatory, and adaptive components causing major part of the tissue destruction 
indirectly. Direct damage from the microbial products constitutes a minor part of 
the total tissue loss [16, 17]. Gingivitis is an inflammation of the gingiva, limited to 
soft-tissue compartment of the gingival epithelium and connective tissue only and 
the tooth does not suffer an attachment loss [18]. Periodontitis, on the other hand, is 
an inflammation of the supporting tissues of the teeth with progressive attachment 
loss and bone destruction [19, 20].
Many investigations have been conducted in diverse areas worldwide. A variable, 
yet significant prevalence of the periodontal disease has been noted, which amounts 
to an enormous disease burden in the domain of public health. The National 
Institute of Dental and Craniofacial Research refer to periodontal diseases as the 
leading cause of tooth loss in adults [21]. In 2013, Marcenes et al. ranked periodon-
titis as the sixth most prevalent condition while estimating the global burden of oral 
conditions from 1990 to 2010 [22]. Moreover, severe periodontitis is considered as 
the primary cause of disability-adjusted life years (DALYs) s in the age-group of 
35- to 59-year-old. Several studies have reported the prevalence of periodontitis in 
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the United States [23, 24]. The overall prevalence of periodontitis was 66% for all 
seniors 65 years of age or older with males being predominantly affected [25].
Prevalence of the periodontal disease varies in different regions of the world 
and a higher prevalence and severity of periodontal disease in Asian countries has 
been reported [26]. The authors looked into the geographic and economic risk 
factors, oral health  distribution and practices in these vast groups of countries to 
enhance understanding regarding the oral health care needs and formulating health 
policy decisions [27]. A study from Pakistan revealed that 63.5% of the subjects had 
Community periodontal index score ≤ 2 while 34.5% had ≥3. Age, gender, occupa-
tion, smoking, diabetes, arthritis, cardiovascular disease, kidney disease, stress, 
medications, and oral hygiene habits of using tooth powder or tooth brushing were 
significantly associated with periodontal status [28]. Multiple studies to understand 
the occurrence, prevalence, and all associated factors have been carried out in many 
states and across the country in India also [29–34]. A systematic review pointed 
out that due to lack of homogeneous studies, it is difficult to estimate an overall 
prevalence rate. A nationwide multicentric prevalence studies initiative is needed to 
obtain the true prevalence rate of periodontal disease in India so that interventions 
should be provided for the same to maintain the oral health and quality of life of the 
affected population [29–34].
2.1 Clinical features of periodontitis
Generally speaking, periodontal disease is a chronic silent disease, which 
barely has any symptoms at an early stage. Most patients suffering from chronic 
periodontal disease seek treatment very late by the time the disease has progressed 
significantly. Redness or bleeding of gums with or without tooth brushing or 
flossing or biting into hard food, repeat episodes of gingival inflammation, oral 
malodor or bad breath, and a persistent metallic taste in the mouth. In progressed 
disease, gingival recession, resulting in loss of gums exposing the roots of teeth, 
deep pockets between the teeth and the gums mobile teeth, in the later stages, drift-
ing and flaring of incisors, increased spacing between the teeth, tendency to dig 
between the teeth, packing of food in between teeth, itchy gums, sensitivity to hot 
and cold foods. Periodontal disease is generally regarded as painless. Patients gener-
ally consider only bleeding without pain from gums with or without brushing as an 
insignificant sign; however, this may be indicative of ongoing disease activity and 
progression of chronic periodontitis. Poor oral hygiene, soft sticky deposits, that is, 
dental plaque and hard mineralized subgingival as well as supragingival calculus are 
frequent findings of periodontal disease [35].
2.2 Periodontal pathogenesis
Periodontitis is a chronic multifactorial disease causing inflammation of the 
supporting tissues of teeth mediated by the host, which is associated with an imbal-
ance in the existing microbial flora in dental plaque and resulting in a continuous 
loss of tooth-supporting apparatus [36, 37]. The bacteria in the dental plaque are 
the essential initiators of the gingival inflammation; however, not all cases suffering 
from gingivitis progress into periodontitis. This transition is largely determined by 
the host immune response. Once gingival inflammation is set in, tissue microenvi-
ronment changes and causes an alteration in the microbial ecology and also in host 
response mechanisms against the residing bacteria. This leads to the stimulation of 
several key molecular and cellular signaling pathways, which ultimately activate 
host-derived collagenases [matrix metalloproteinases (MMPs)] which are respon-
sible for tissue destruction. Such lytic process cause loss of principal fibers of the 
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periodontal ligament, apical migration of the gingival attachment, and allows apical 
extension of biofilm and subjacent inflammation along the root surface and further 
spreads the disease process [36]. It leads to loss of clinical attachment, pocket for-
mation, sometimes gingival recession, and radiographically accompanied bone loss 
[37, 38]. Gingivitis is a completely reversible disease process and the essential first 
step to progression to periodontitis, suggests periodontitis can be prevented at its 
early stage, yet it remains one of the most common causes of tooth loss. Therefore, 
prevention and early detection of periodontal disease are essential to reduce the 
damages it implies to the oral and systemic health of the individual.
2.3 Alveolar bone loss in periodontal disease
Alveolar bone loss is a characteristic sign of advanced periodontitis and ongo-
ing bone loss is characteristic of the progression of periodontitis. The prevention of 
periodontal disease progression and bone loss is a key clinical challenge in periodontal 
therapy. Bone destruction is an eventual outcome of the host immune and inflamma-
tory response and the dental plaque microbial challenge interplay. However, the under-
lying mechanism of disruption of the homeostatic balance of bone formation and 
resorption in favor of bone loss in these clinical situations remains to be understood.
2.3.1 Immunopathogenesis of periodontal bone loss
In chronic periodontal disease, many bioactive microbial molecules from dental 
plaque incite an immunological response from the resident and immune cells pres-
ent in gingiva and periodontal tissues [39]. This leads to an influx of multiple cyto-
kines that mediate the biochemical pathways of inflammation, for example, PGE2, 
IL-1, TNF-alpha and RANK-L, etc., which are responsible for osteoclastogenesis, 
the primary bone-resorbing process. Thus, the pathologic inflammatory process 
disrupts the fine balance between protective and destructive processes and leads to 
initiation of osteoclastic activity [40–45]. “Osteoimmunology” is the science which 
is dealing with the understanding of the intricacies of this immune-mediated bone 
destruction [46, 47]. The cellular inflammatory infiltrates of periodontal immunity 
cells such as T cells, B cells, macrophages, and neutrophils are increased within the 
gingival connective tissue and a concurrent increase in the inflammatory media-
tors’ production is also evident [48, 49]. RANKL-mediated osteoclastogenesis is the 
prime mechanism underlying the inflammatory bone resorption in periodontal tis-
sues [43, 50]. Activated T and B lymphocytes in inflamed periodontal tissues are the 
prime producers of RANKL- [43, 44, 51, 52]. An increase in osteoclast numbers on 
the alveolar bone crest has been observed in animal studies where antigen-specific 
lymphocytes are present and which can be suppressed by OPG [51, 53, 54].
Heterogenous populations of gingival fibroblasts are involved in dual actions 
in the inflammatory process. They are documented to have a protective role to 
suppress osteoclast formation as they produce OPG in response to LPS and IL-1; 
however, they may also augment chronic inflammatory processes through IL-6 and 
IFN production. The known periopathogens Aggregatibacter actinomycetemcomitans 
(Aa) and Porphyromonas gingivalis (Pg) induce the production of RANKL from the 
resident cells of periodontium viz. osteoblasts and gingival fibroblasts. Recently, 
it has been shown that an increased RANKL/OPG ratio is associated with periods 
of tissue destruction and ongoing disease activity. This ratio is further upregulated 
in patients in the presence of other known risk factors, for example, smokers and 
diabetics [55]. It has also been reported that the molecular mechanisms of T cell-
mediated regulation of osteoclast formation occurs through cross talk signaling 
between RANKL and IFN-gamma [56].
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2.3.2 Patterns and trends of alveolar bone loss
Periodontitis is usually asymptomatic chronic inflammatory condition caused 
by bacterial aggregation which affects the crest of the alveolar process by reduc-
ing the normal height in a vertical and/or a horizontal manner; furthermore, bone 
loss might be presented in a localized or a generalized form [35]. Bone destruction 
can be detected using several radiographical techniques that evaluate the quantity 
of the remaining bone and subsequently estimating the amount of bone loss on a 
radiograph. Panoramic radiography has a little diagnostic value in the identification 
of periodontal disease. It is useful to obtain the overall generalized status of bone, 
rather than very fine or precise details. However, it can be used as a valuable adjunct 
to conventional diagnostic procedures. It can be recommended as a part of routine 
dental and periodontal assessment which captures the entire maxilla-mandibular 
radiographic image on a single film. However, a panoramic radiograph should not 
be used to replace other intraoral radiographic techniques. Semenoff et al. assessed 
variations between different dental radiographs for assessment of the interseptal 
bone crest loss on conventional and digitized periapical, bitewing, and panoramic 
radiographs. Comparison among them showed that a small reduction in height of the 
interseptal bone crest observed in panoramic radiographs should be carefully evalu-
ated for overestimation. Moreover, several studies proposed that panoramic radiog-
raphy might serve as a diagnostic aid in dental health evaluation programs [57].
2.3.3 Bone destruction patterns in periodontal disease
Periodontal disease may affect the bone, altering its morphologic features in 
addition to reducing the vertical level of the bone height. An understanding of 
tissue mechanisms causing these alterations is important for effective diagnosis and 
effective treatment modalities.
I. Goldman and Cohen 1958 [58]: Classified infrabony defects based on the loca-
tion and number of osseous walls remaining about the pocket as.
• Three osseous walls:
 ○ Proximal, buccal, and lingual walls
 ○ Buccal, mesial, and distal walls
 ○ Lingual, mesial, and distal walls
These trough-like defects are mostly seen in the interdental areas. These may 
exist as either shallow and wide lesions or deep and narrow ones.
• Two osseous walls:
 ○ Buccal and lingual walls (crater)
 ○ Buccal and proximal walls
 ○ Lingual and proximal walls
Two wall infrabony pockets may also occur in the interdental areas. With the 
buccal and lingual walls intact, but lost proximal wall, the lesion is termed as an 
intraosseous interproximal crater.
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• One osseous wall:
 ○ Proximal wall (hemiseptum)
 ○ Buccal wall
 ○ Lingual wall
Generally in these lesions, a proximal wall is present with both buccal and 
lingual walls’ resorbed.
• Combination:
 ○ 3 walls +2 walls
 ○ 3 walls +2 walls +1 wall
 ○ 3 walls +1 wall
 ○ 2 walls +1 wall
They may be seen in a variety of combination forms and can be located on a 
single or multiple surface of a tooth (Figure 1).
II. Karn KW et al. 1983 [59]:
1. When the original topography of the alveolar process is altered by uniform loss 
of bone from around the teeth and the plan of bone remains perpendicular to 
the long axis of the tooth: Horizontal bone loss
2. Deformities created by nonuniform loss of bone are based on the following 
basic terms:
a. Crater: A crater is formed as a result of loss of alveolar bone and a portion 
of the contiguous supporting alveolar bone from only one surface of a 
tooth. They are identified by the mesial, distal, facial, or lingual tooth sur-
face involved. Craters may be confluent if they occur on adjacent proximal 
surfaces, and termed as two-surface craters (affecting two tooth surfaces), 
named with two teeth involved.
Figure 1. 
Showing wall defects.
7Gender-Associated Oral and Periodontal Health Based on Retrospective Panoramic…
DOI: http://dx.doi.org/10.5772/intechopen.93695
b. Trench: When bone loss as mentioned for crater affects two or three 
confluent surfaces of the same tooth, it is known as a trench. Trenches can 
be similarly identified by the tooth surfaces involved (e.g., mesiofacial and 
mesio-lingual- distal). There are eight possible types of trenches (MF, ML, 
DF, DL, MFD, MLD, FML, and FDL).
c. Moat: When bone deformities involves all four surfaces of a tooth. Only the 
tooth number is necessary to identify it (Figure 2).
d. Ramp: When both alveolar bone and its supporting bone are lost to the 
same degree but that the margins of the deformity are at different levels, 
it is known as Ramp. These are named for the tooth surface aspect from 
which the greatest bone loss has occurred and the teeth involved.
e. Plane: It is similar to ramp but the margins of the deformity remain at the 
same level. It can be considered horizontal bone loss about one tooth or 
portion of a tooth (Figure 3).
f. Cratered ramp: If only the most coronal rim of the deformity were con-
sidered, it would represent a ramp. However, a crater is presenting apical 
to the entire extent of the ramp and hence the term “cratered ramp.” It is 
basically a crater with a portion of its facial and/or lingual wall missing. 
Cratered ramps are named for the teeth involved, the aspect of the alveolar 
process from which bone has been lost in the ramp portion and the tooth 
surfaces involved with the crater (or trench) (Figure 4).
Figure 2. 
Showing a moat type of bone defect.
Figure 3. 
Showing a plane type of bone defect.
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Figure 5. 
Showing ramp into a crater type of bone defect.
g. Ramp into A Crater or Trench: Its salient characteristic is that it is a 
ramp in the coronal aspect, but distinctly a crater or trench in the apical 
portion (Figure 5).
h. Furcation invasions: It refers to the involvement of the furcation area of the 
teeth by any kind of bone loss patterns described above.
III. Prichard JF 1983 [60]: Classified the bone defects as follows:
a. Intrabony defect: It is surrounded by bony walls on three sides and the 
root of tooth forming the fourth wall. The walls may be at different levels 
coronally forming combinations with other defects, but only the “inside” of 
the defect, the part that is apical to all three bony walls, is “within” bone or 
intrabony. They are also found in the apical region where the base of the arch 
is usually wider than the crest.
b. Hemiseptum: Periodontitis may affect one tooth and destroy septal bone 
adjacent to that tooth without affecting the contiguous tooth, thus leaving a 
hemiseptum of interalveolar bone.
Figure 4. 
Showing cratered ramp type of bone defect.
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c. Inconsistent margins: Destruction of marginal bone usually creates what 
Schluger called an inconsistent margin and on the tooth root the marginal 
defect may expose a furca. Across the interproximal space, the inconsistent 
margin may be associated with a crater or a hemiseptum.
d. Crater: A crater is a wide-mouthed cup or bowl-shaped defect in the interal-
veolar bone, with bone destruction about equal on the roots of the contigu-
ous teeth; the sidewalls of the crater are formed by marginal bone on the 
vestibular and lingual surfaces.
e. Furca involvement: In the maxilla, defects in the interalveolar bone may be 
complicated by exposure of a furca and there may be bone destruction in the 
interradicular area.
2.3.3.1 Progression of periodontal disease
The earlier viewpoint regarding the progression of periodontal disease was 
that bacterial plaque accumulation universally leads to gingivitis, with subsequent 
progressive destruction of the supporting tissues of periodontium, with continuous 
irreversible attachment loss and bone resorption over time. Such conclusions have 
mostly come from observing cross-sectional populations over long periods of time. 
Later In order to determine the rate, pattern, and course of bone loss, researchers 
longitudinally studied subjects with repeated clinical and radiological measurements 
of patients suffering from periodontitis. Papapanou and coworkers [61] studied 
over 200 subjects with full-mouth radiographic surveys taken 10 years apart. The 
findings revealed that the mean annual rate of bone level resorption varied by age. 
Subjects between the ages of 25 and 65 years exhibited between 0.07 and 0.14 mm/
year; whereas subjects over 70 years of age had a significantly higher rate of bone loss 
(0.28 mm). This particular investigation gave an insight into the trend of alveolar bone 
loss that it was continuous, slowly progressive, but with a great deal of the variable 
rate of progression among teeth and subjects. A similar 6-year long study in elderly 
Chinese subjects also revealed the individual range of bone loss varied dramatically 
from 0 to 0.53 mm/year [62]. Similar observations had been seen from the previous 
classically cited study by Löe and coworkers in Sri Lankan tea workers [63], which also 
reported huge differences in the rate of periodontal destruction among individuals.
Goodson and coworkers [64] challenged the prevalent belief system at that 
time that oral bone loss proceeded in a gradual fashion. In a series of studies, they 
examined the individual tooth site for progressive bone loss [65–68]. Among 22 
untreated subjects with existing chronic periodontitis and pockets due to bone loss, 
only 15 subjects witnessed significantly deeper pockets over a time span of 1 year, 
whereas the other tooth sites rather showed a gain in attachment and reduction in 
the existing pocket depths. This investigation provided the evidence that alveolar 
bone destruction associated with periodontal disease was a dynamic condition and 
exhibited exacerbations and remissions of the disease activity over a period of time. 
This led to the emergence of “burst model” for periodontal disease progression 
pattern which had irregular bouts of the disease activity as opposed to continuous 
slow bone destruction over time. These classic studies utilized conventional manual 
probing to measure clinical attachment-levels to identify specific sites exhibiting 
more than 2 mm of progressive attachment loss and merely 5% of tooth sites exhib-
ited progressive attachment loss. Another study [69] revealed 29% of the tooth sites 
showing progression over a 6-month period in adult patients previously diagnosed 
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with periodontitis, by utilizing a more sensitive electronic probe to measure 
attachment loss. Modeling of the data over time showed that 76% of tooth sites lost 
attachment consistent with linear patterns, 12% of tooth sites showed exacerba-
tions and remissions, and 12% revealed bursts of disease activity. Since then, a lot 
of periodontal disease progression models have come into being based on diverse 
studies, for example, Socransky, Goodson 1984 [70]. (1) Continuous Models: Slow 
and continuous, constantly progressive rate of destruction throughout the duration 
of the disease. (2) Random or episodic burst model: Short bursts of destruction fol-
lowed by periods of no destruction, random pattern of disease w.r.t. the tooth sites 
affected. (3) Asynchronous, multiple burst model: periodontal destruction occurs 
in bursts, around affected teeth during defined periods of life. The chronology of 
these bursts of disease is asynchronous for individual teeth or groups of teeth. The 
natural history and progression patterns of intraoral bone loss are yet not clearly 
and completely understood at this time [71].
3. Risk factors for periodontal disease
Several studies’ results indicated d that the tooth loss associated with periodontitis 
was much higher than the number of persons who suffer such tooth loss [72, 73]. 
Although a large proportion of the population is susceptible to periodontitis, yet a 
very small segment of the population witnesses severe forms of periodontitis. Such 
observations about the differential disease susceptibility led to the emergence of the 
concept of risk factors impacting the periodontal disease expression [74]. A risk factor 
is defined as an environmental, behavioral, or biologic factor confirmed by temporal 
sequence, usually in longitudinal studies, which if present, directly increases the like-
lihood of a disease occurring, and if absent or removed, reduces the probability of the 
disease event. Risk factors are considered as a part of the causal chain or expose the 
host to the causal chain. The most salient feature of a risk factor is its temporal pres-
ence before the emergence of the disease itself. Risk factors can be both modifiable 
and non-modifiable. Once a disease occurs, the removal of a risk factor may not result 
in a cure [75–77]. Based on whether they can be modified or not and documentation 
of their strength of association with the consequent disease, these have been classified 
as different categories as risk factors per se as defined, risk determinants, risk indica-
tors, and risk predictors. Risk indicators are probable or putative risk factors that have 
been identified in cross-sectional studies but not confirmed through longitudinal 
studies. Risk predictors/markers, although associated with increased risk for disease, 
however, have not been clearly known to cause the disease. Risk determinants or 
background factors are those which are seen to be associated with the disease, but are 
not modifiable.
The contemporary concept that the rate of progression, age at onset, and 
severity of periodontal disease in an individual are often determined by systemic 
risk factors in the host is a recent one, supported by epidemiologic investigations of 
periodontal disease and the role of an associated multitude of genetic, epigenetic 
and environmental risk factors.
3.1 Age and gender as a risk determinant for periodontal disease
3.1.1 Age
Epidemiological studies have revealed a higher prevalence of the periodontal 
disease in elderly people compared to younger age-groups. The evidence demon-
strates that both the extent and severity of periodontal disease increase in older 
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individuals. Whether the increased prevalence and the severity in older persons are 
the outcomes of the lifetime accumulation of local factors such as dental plaque and 
microbial deposits or an inherent greater chance of susceptibility to periodontal 
deterioration exists in them remains largely debatable. Aging is associated with an 
increased incidence of periodontal disease [5, 6]. In a cross-sectional investiga-
tion of 1426 individuals aged 25–74 years, age was the most strongly associated 
risk factor with clinical attachment level with an odds ratio of 1.2 for persons aged 
35–44 years and 9.01 for subjects aged 65–74. A stronger association between age 
and alveolar bone loss was seen in the same body with odds being 2.6 for people 
aged 35–44 years and 24.08 for age-group 67–74 years. Similar associations were 
reported in a large military population from the United States (1783 subjects) 
with an odds ratio of 5.03. Brown et al. reported contradictory findings and found 
age as not related to attachment loss in older individuals. Ismail et al. found that 
average attachment loss was greater in older individuals over a period of 28 years, 
though statistically not significant association, but significant in a multivariate 
model. Abdellatif and Bart [4] evaluated the relative significance of age and oral 
hygiene status as determinants of periodontitis and reported the rate of increase of 
periodontitis with increasing age across all age-groups was much higher for those 
with poor oral hygiene than those with excellent oral hygiene. They concluded that 
the effect of the age as a risk factor on periodontal disease progression is minimal 
when coupled with good oral hygiene [78]. Several studies show that the prevalence 
and severity of periodontal disease increase with age [79–86]. Papapanou et al. 
demonstrated that the mean annual rate of bone loss among the initially 70-year-
old subjects was 0.28 mm compared to 0.07 on the 25-year-old individuals [86]. The 
increased severity of periodontal disease and bone loss with age was attributed to 
the time period, for how long the etiologic factors have been present in contact with 
the periodontal and is considered to reflect an individual’s cumulative risk contact 
history [87]. More studies carried out in some of the developed countries show 
changing patterns of periodontal disease progression. These studies have shown 
that advanced periodontal destruction and bone loss are seldom seen in individuals 
under the age of 40 [83, 88]. A similar finding has been observed even in the elderly 
population. Studies among the elderly have shown that advanced periodontal dis-
ease affects only a small fraction of this age-group [82, 88]. However, among those 
with advanced disease, further breakdown does occur with increasing age [89].
Thus, the increased level of periodontal destruction observed with aging is now 
considered as the result of cumulative destruction rather than a result of increased 
rates of destruction. Thus aging is not a risk factor per se [76, 79] but enhances the 
susceptibility of greater incidence, prevalence, extent, and severity of periodontal 
disease owing to cumulative damage caused by local and other contributing etio-
logic factors over a period of time.
3.1.2 Gender
Gender has been associated with the diverse occurrence of periodontal disease 
in population studies and generally, males are known to suffer greater from gum 
disease than females of comparable age. Males usually exhibit poorer oral hygiene 
compared to females also. However, when oral hygiene, socioeconomic status, age, 
is correlated with gender, males are found to be associated with more severe peri-
odontal disease. Females are more hygiene and esthetics conscious and seek dental 
treatment more often when compared to males. In their life span, there are gingival 
inflammatory conditions consistent with the physiologic reproductive hormonal 
fluctuations at different stages, such as puberty, pregnancy, and menopause [78]. 
Most of the data regarding the effect of female gender on gingival and periodontal 
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tissues come from the clinical manifestations of inflammatory responses during 
specific periods of reproductive life such as puberty, pregnancy, and menopause, 
periods of immense alterations of female sex hormones. More gingival inflamma-
tory diseases have been documented in association with sex steroid hormone levels, 
even without any alteration in the oral hygiene level of the individual. There is 
recent mounting evidence suggesting alterations in the male periodontium com-
miserating with androgen level fluctuations, in addition to most studies conducted 
in premenstrual females [90]. There is largely inconclusive evidence for the role 
of gender as a discriminating factor, in prevalence, progression, and severity of 
periodontal disease [3].
Numerous studies reported higher periodontal destruction among males 
compared to the female population. A high prevalence of periodontal disease of 
73.9% was found among Chinese pre-conception women. Self-reported frequent 
bleeding during tooth brushing and the increased rate of periodontal disease 
revealed statistically significant association [91, 92]. Shaizu et al. in a systematic 
review and meta-analyses estimated sex-related differences in the prevalence 
of periodontitis. They found that sex exhibited a significant association with 
prevalence, reflecting a 9% difference between males and females (37.4 vs. 28.1%, 
respectively), although the overall effect of sex in the meta-analysis was compara-
tively small (d = 0.19; 95% confidence interval, 0.16 and 0.22). They calculated 
the mean difference in prevalence between males and females to be the same 
regardless of the severity of disease threshold and after adjustment for other risk 
factors. They concluded that men appeared at greater risk for destructive peri-
odontal disease than women; however, men do not appear at higher risk for more 
rapid periodontal destruction than women. Recently, Hass et al. [93] reported 
almost two-fold higher susceptibility to suffering from periodontitis but similar 
periodontal status in postmenopausal women not on hormone replacement 
therapy (HRT) as compared to premenopausal women [94]. The reasons for these 
sex differences are not clear but can be related to multiple aspects, for example, as 
a demographic, biological, genetic, or epigenetic [95, 96]. However, the relation-
ship observed between sex and the disease is not apparent and is not considered as 
strong and consistent [89].
3.1.2.1 Periodontium as a target tissue for sex steroid hormones
Sex steroid hormone receptors are not uniformly distributed but are found con-
centrated in certain hormone-sensitive tissues known as target tissues. Preferential 
accumulation and retention of hormones may occur depending upon the number 
of cytoplasmic and nuclear receptors that bind to particular hormones within the 
tissue. Many investigations have reported the preferential localization and retention 
of sex steroids, for example, estrogens [97, 98], androgens [98] and progestins [99] 
in periodontal tissues as well [90, 100]. The presence of specific hormonal recep-
tors determines the response and regulates gene expression regarding the specific 
hormone ligand [101].
There are two kinds of estrogen receptors (a and b) which are genetically 
distinct forms and have differential distribution and functions [102]. Upon binding 
to a receptor, the activated receptor-steroid hormone complex binds with specific 
nuclear sites with a strong affinity. The intracytoplasmic or intranuclear activation 
step, followed by gene activation and transcription of mRNA finally guides the 
cellular protein synthesis. All sex steroids have effects on cell membranes and thus 
affect the second messenger systems in addition to regulation of gene transcrip-
tion [103]. These activities affect neural transmission [104], modify the transport 
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of calcium ions into cells [105], and stimulate the intracellular concentration of 
polyamines [106]. The periodontium of humans and animals is equipped with all 
the necessary enzymatic machinery to metabolize sex steroid hormones by common 
metabolic pathways and increased metabolic activity has been reported in inflamed 
periodontal tissues [3, 100, 101, 107, 108].
3.1.2.2 Proposed mechanisms for sex-specific hormones effecting periodontal 
disease pathogenesis
3.1.2.2.1 Periodontal microbiota
The majority of scientific investigations have not been able to identify any 
remarkable differences in periodontopathogenic bacteria between males and 
females [109–111]. Kumar et al. (2013) reviewed the effects of gonadal hormones 
on oral microbiota and documented only a transient alteration in the number and 
proportions of specific microorganisms during puberty or pregnancy [112]. So, 
there is not enough support that such minor and transitory relationships can bear a 
significant effect on susceptibility for periodontal breakdown [113, 114].
3.1.2.2.2 Vasculature
Similar to reproductive system vasculature, the blood vessels of gingiva is also 
responsive to sex steroid hormones. Many scientific investigations have correlated the 
increased flow of GCF, coinciding with the periods of fluctuation of sex steroid hor-
mones. A comparison of the amount of gingival crevicular fluid in pregnant women 
versus postpartum controls has revealed approx. 54% elevation in pregnant females 
[115]. In a few animal studies, exogenous estrogen and/or progesterone administra-
tion has shown a significant increase in the amount of crevicular fluid irrespective of 
the inflammatory status of the status [116–118]. Both estrogen receptors a and b have 
effects on blood vascular functions [119].
Several mechanisms have been put forth to explain how the hormone may 
control the tonicity of the blood vessels by:
1. Inhibiting the calcium ions through the voltage-sensitive calcium channels [120].
2. Influencing the sympathetic transmitters [121, 122], or affecting alpha-adreno-
ceptor number or affinity [123, 124].
3. Increasing capillary permeability by stimulating the release of various 
mediators (e.g., adenosine, bradykinin, vasoactive intestinal polypeptide, 
neurotensin, substance P, various prostaglandins, AMP, ADP, ATP, cAMP, 
guanosine, thymidine, histamine, cytidine, uridine, acetylcholine, isoproter-
enol, and glycosaminoglycans) [125]. Some evidence regarding nitric oxide-
induced vasodilation, re-endothelialization angiogenesis have also been 
accounted for such alterations through activation of the estrogen receptor-a 
[119, 126]. However, progesterone has been known to oppose the actions of 
estrogen, presumably by reducing estrogen receptor numbers, rather than 
having any individual effects on vasculature [90, 125].
Resident Cells Estrogen is known to regulate periodontal ligament cell pro-
liferation including fibroblasts, keratinocytes, and promote osteoblastic cell 
differentiation [127, 128].
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3.1.2.2.3 Epithelial cells
Several investigators perceived that estrogens increased epithelial keratinization 
and stimulated proliferation [129, 130]. Trott noticed a reduction in keratinization 
of the marginal gingival epithelium in postmenopausal women when plasma estro-
gens levels were declining [131]. Androgens were perceived to stimulate an increase 
in epithelial cell number [132, 133].
3.1.2.2.4 Connective tissue cells
The cellular effects of estrogen on collagen synthesis may largely be organ or 
site-specific [134]. In contrast to testosterone and progesterone, estrogens appear 
to be stimulatory in gingival fibroblasts derived from either feline or human drug 
enlarged gingiva [135]. Mariotti reported increased cell proliferation in fibroblasts 
derived from clinically healthy human gingiva of premenopausal women, with 
physiological concentrations of estradiol in vitro. They reported a characteristic 
estrogen-sensitive cellular subpopulation within the whole parent cell population 
of fibroblasts from premenopausal women [136]. Estradiol also induces a dose-
dependent increase in interleukin-6, interleukin-8, and vascular endothelial growth 
factor in gingival fibroblasts [137]. In periodontal ligament cells, estrogens caused 
downregulation of lipopolysaccharide-induced cytokines while enhancing the 
production of osteoprotegerin [138, 139]. Natoli et al. demonstrated the expression 
of matrix proteins including collagen, elastin, and fibrillin-1, and their regulators as 
impacted by estrogen [140].
3.1.2.2.5 Bone cells
Sex steroids play a critical for skeletal development and for the maintenance of 
bone health throughout adult life [141]. The deficiency of estrogen increases osteo-
clast precursor cells. Estrogen increases osteoprotegerin, upregulates transforming 
growth factor-beta, an inhibitor of bone resorption that acts directly on osteoclasto-
genetic cells to decrease activity and increase apoptosis [142–144].
Specifically, increased T-cell production of tumor necrosis may be mediated 
by estrogen deficiency via a mechanism dependent upon regulatory cytokines, for 
example, in vivo bone destruction has been shown to involve interleukin-7, prob-
ably through its influence on T-cell development and homeostasis [141, 145].
3.1.2.2.6 Immune cells
Straub proposed that sex steroid hormones modulate the immune system via 
multiple ways: the immune stimulus and antigen-specific immune response; the 
target cells involved; the microenvironment of the tissue; hormone concentration; 
the variability of receptor isoforms; and the intracellular metabolism of hormones 
to either biologically active or inactive forms [146–148].
3.1.2.2.7 Intracellular signaling
Infectious challenge studies have revealed that males produce a significantly 
higher level of the inflammatory cytokine IL-6 and the acute phase protein LPS-
binding protein (LBP) than females, after in vivo endotoxin exposure male-derived 
macrophages produce higher levels of IL 1b and lower levels of prostaglandin E2 than 
similarly treated female derived cells on exposure to LPS [147]. Estrogen and proges-
terone have antagonizing effects on neutrophil chemotaxis [149, 150]. Estrogen has 
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been shown to upregulate nitric oxide synthase expression in neutrophils ex-vivo, 
with nitric oxide production being the highest [151, 152].
3.1.2.2.8 Adaptive immunity
B cells: documented evidence suggests that estrogen acts as a polyclonal B cell 
activator and has been shown to alter B lymphocyte function. Estrogen inhibits 
CD8+ T- cell-mediated suppression of B cells, the accelerated maturation of B cells 
into plasma cells; or increased amounts of the antibody produced per cell [152]. 
Similar findings have been demonstrated in animal models [153]. Testosterone has 
been shown to inhibit immunoglobulin IgG and IgM production of peripheral blood 
mononuclear cells [154].
T cells: Estrogen displays a biphasic effect on the antigen-stimulated secretion 
of TNF-α, with inhibition at high concentrations and enhancement at low doses 
[155]. Pregnancy and periovulatory levels of estrogen enhance IL-10 and IFN-γ 
response in CD4+ cells in humans and mice [156]. Estrogen inhibits IL-6 cytokine 
production in T cells. In healthy men and women, the polarization of immune 
response into Th1 or Th2 cytokines or cellular types is not absolute but the ratio of 
these components varies according to physiological demand and clinical conditions 
[157, 158]. Estrogen is known to be a potential physiological regulatory factor for 
the peripheral development of CD4 + CD25+ Treg cells [159]. Additionally, it was 
discovered that hormones peripherally activated prohormones and regulated the 
Th1/Th2 balance [160–163].
3.1.2.2.9 Antigen-presenting cells
(APCs) regulate Th cell differentiation and Th cell functioning under resting 
and activated conditions of the immune system in both the gender.IL6pathways 
regulates the homeostasis of the Th cell network in women, while this homeostasis 
is regulated by IFNγ pathways in men. Physiological homeostasis between Treg, 
Th17, and Th9 cells in the resting state in the transition to the activation phase and 
in the return to the resting state [157].
3.1.2.2.10 Immunosenescence-Gender-specific effects
Contemporary studies about the immune system functions have documented 
that there exists a differential effect on the activities and regulation of T helper 
(Th) cytokine pathways, which is affected by aging, but not to the same extent in 
both genders. Different cytokines regulate the development of immune response 
in humans at different phases, based on gender, for example, early evolution by 
the positive inter regulation of IFNγ-IL10 and IL6-IL4 in males, and the negative 
interrelation of IL6-IL10 in females whereas, the late evolution by the positive inter 
regulation of IFNγ-IL4 in males and by IL6-IFNγ in females. Alterations in these 
gender-specific cytokines regulatory pathways during aging could adversely affect 
the success of the immune response [158].
4.  Preliminary case study: a retrospective panoramic analysis of 
distribution patterns of alveolar bone loss in chronic periodontitis 
patients from North India
A small preliminary investigation designed as a hospital based retrospective 
study of distribution patterns of alveolar bone loss on panoramic X-rays (OPG) 
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Figure 7. 
Method of estimating alveolar bone height on panoramic radiographs using image analysis software.
of chronic periodontitis patients from North India was planned to draw an insight 
regarding the differential role of gender in context of periodontal disease. The aim of 
this study was to conduct an orthopantomograph radiographic screening in order to 
determine the overall distribution of alveolar bone loss, patterns (horizontal/verti-
cal), and extent (coronal, middle, and apical thirds of the tooth root) in population 
by digital measurement analysis based on age and gender of the study participants.
4.1 Materials and methods
Orthopantomographs (OPG X-rays) of a total of 64 patients who visited the 
Department of Periodontology in the month of February–March, 2020 were recruited 
from the records, in order to evaluate the interproximal alveolar bone loss and poten-
tial explanatory variables including age, gender and number of sites. Panoramic views 
were obtained using Planmeca 2002 CC Proline with Dimax 3, Panoramic digital 
X-ray unit (60 KV and 20 mA), 1.2 magnification ratios. The scanned version of 
OPG X-ray films were analyzed with the help of a publicly available free online image 
assessment tool viz. Image J. It is a Java-based image processing program developed at 
the National Institutes of Health and the Laboratory for Optical and Computational 
Instrumentation (LOCI, University of Wisconsin). [163, 164]
A digital method of estimating alveolar bone height on panoramic radio-
graphs using 3X magnification was employed using constant anatomic land-
marks as reference points - CEJ and alveolar crest as shown in Figures 6 and 7. 
Figure 6. 
Digital OPG X-ray image.
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Bone loss was considered when the distance from the CEJ to the alveolar crest 
exceeded 2 mm. Radiographic images was interpreted by a single calibrated 
examiner in order to reduce variability in image assessment and recording 
of data. Distorted, overlapped, unclear images particularly at the maxillary 
and mandibular anterior region or patients with orthodontic appliances were 
excluded for evaluation. Bone loss was estimated digitally by measuring the 
distance between CEJ and alveolar crest at the interproximal areas minus 2 mm 
(physiologic high of interseptal alveolar crest) at sites with reduced normal level 
of interseptal bone. The data so collected was put to appropriate descriptive 
and inferential statistics. Student, s T test and Mann Whitney test was used to 
intercept the differences in the mean of normal and skewed data parameters for 
different categories resp. Further, odds ratio was calculated to predict the future 
bone loss trends for patients with existing periodontal bone loss based on the no. 
of sites involved in bone loss.
4.2 Results
The collected OPG X-rays were categorized according to age and gender based 
on the accompanying clinical history recording and it was observed that there were 
OPGs from 30 females and 34 males and 11 subjects were below 30 years of age and 
53 were above 30 years of age (Table 1).
Table 2 demonstrates the mean age and the distribution of bone loss patterns in 
total study population based on different defined categories of the bone loss provid-
ing mean no. of bone loss sites, along with the observed range in each category. As 
the study population was chronic periodontitis patients, all radiographic images 
showed evidence of bone loss at one or more than one site. Overall, 17 sites of 
bone loss were observed as an average no. of bone loss sites in the total population. 
Similarly, a mean value of 9.69 and 7.50 was observed for horizontal and vertical 
kind of bone loss sites in all population. The no. of bone loss sites extended to 
coronal, middle third and apical third of the root surface revealed a mean score of 
3.11, 11.45, and 2.52 per individual, respectively (Table 1).
Tables 3 and 4 reveals comparative analysis of gender and age based distribu-
tion of total no. of bone loss sites in the total study population in current study. 
According to the gender, there was not observed any statistically significant differ-
ence in the total no. of bone loss sites, whereas there existed significant difference in 
the total no. of bone loss sites as per age.
Tables 5 and 6 reveals genderwise distribution of no. of bone loss site based 
on categories and its comparatives analysis, respectively. None of the categories 
revealed statistically significant difference in the no. of bone loss sites between 
males and females. Similarly, Tables 7 and 8 reveals agewise distribution of no. 
of bone loss site based on categories and its comparatives analysis, respectively. 
Statistically significant difference in the no. of bone loss sites between males and 
No. of subjects Category Frequency Percent Valid percent Cumulative percent
64 Females 30 46.9 46.9 46.9
Males 34 53.1 53.1 100.0
<=30 years 11 17.2 17.2 17.2
>30 years 53 82.8 82.8 100.0
Table 1. 
Distribution of study participants based on categories.
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Sex Mean N Std. deviation Std. error mean Sig. (2-tailed)
M 17.03 34 5.060 .868 0.998
F 17.03 30 6.568 1.199
Table 3. 
Comparative analysis of gender based distribution of total No. of bone loss sites in study population.
females in the category of subjects with bone loss extending to middle third of the 
root, whereas none of the categories revealed statistically significant difference in 
the no. of bone loss sites between subjects above and below 30 years of age.
Further, a risk estimate analysis based on both age and gender as risk factors was 
carried out for prediction of future susceptibility of bone loss by calculating Odds 
ratio s, which revealed age of the individual as a significant risk determinant for the 
same (Tables 9 and 10).
4.3 Discussion
Gender has been implicated as a risk factor for many human diseases particularly 
rooted in chronic diseases, where disease pathogenesis is impacted significantly 
by immune mechanisms of the body including periodontal disease [165, 166]. The 
findings from the present case study revealed the presence of bone loss in all study 
participants which is indicative of the fact that periodontal bone loss is the hallmark 
of chronic periodontal disease. On average, 17 sites with bone loss were found to be 
S. No Clinical 
Parameters
No. of 
subjects
Minimum Maximum Mean Std. 
Deviation
Median Inter 
quartile 
range
1 Age 64 17 84 41.67 11.982 — —
2 Total No. of 
sites
64 4 29 17.03 5.768 — —
3 No. of 
Sites with 
horizontal 
bone Loss
64 0 26 9.69 5.377 9.00 5–13.75
4 No. of Sites 
with vertical 
bone loss
64 0 22 7.50 5.507 7.00 3.25–10.00
5 Coronal 3rd 64 0 18 3.11 4.303 1.00 0.00–4.75
6 Middle 3rd 64 0 26 11.45 7.322 12.00 4.25–17.75
7 Apical 3rd 64 0 23 2.52 4.922 0.00 0.00–2.00
Table 2. 
Distribution of study parameters in total study population based on different categories.
Age-groups Mean N Std. deviation Std. error mean Sig. (2-tailed)
<=30 years 12.91 11 6.789 2.047 0.008**
>30 years 17.89 53 5.206 0.715
Table 4. 
Comparative analysis of age-based distribution of total No. of bone loss sites in study population.
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present across the study population. Horizontal bone loss was more prevalent than 
the vertical bone loss, which is again in sync with the existing knowledge regarding 
the periodontal bone loss patterns. Most patients suffered from moderate periodon-
titis in terms of the severity of bone loss as maximum sites in population revealed 
bone loss extending up to the middle third of the root surface. With the new 2017 
World Workshop on the Classification of Periodontal and Peri-Implant Diseases and 
Condition as a reference, the majority study population falls under the Stage III peri-
odontitis category based on the residual bone level criteria for categorization [167]. 
Further, there was observed no statistically significant difference in the total num-
ber of bone loss sites based on gender, but there existed a significant difference in 
the total number of bone loss sites as per age in the study population. A statistically 
significant difference in the number of bone loss sites between males and females in 
the category of subjects with bone loss extending to the middle third of the root are 
also revealed, but neither of the other two categories based on age nor all categories 
based on gender witnessed any statistically significant differences in terms of the 
number of bone loss sites varied according to the severity of the bone loss.
Category of patient No. of 
patients
Median Std. 
deviation
Interquartile range
M No. of sites with 
horizontal bone loss
34 9.00 5.132 5.00 13.25
No. of sites with 
vertical bone loss
34 7.50 5.710 4.00 10.00
Coronal 3rd 34 1.00 4.351 0.00 5.00
Middle 3rd 34 12.00 6.881 6.25 16.00
Apical 3rd 34 .00 4.931 0.00 2.25
Sex 34 1.00 0.000 1.00 1.00
F No. of sites with 
horizontal bone loss
30 9.50 5.637 5.00 14.00
No. of sites with 
vertical bone loss
30 6.50 5.078 3.00 10.25
Coronal 3rd 30 1.00 4.321 0.00 4.50
Middle 3rd 30 11.67 7.906 4.00 18.25
Apical 3rd 30 2.43 4.994 0.00 2.50
Table 5. 
Genderwise distribution of No. of bone loss site based on categories.
No. of sites 
with horizontal 
bone loss
No. of sites with 
vertical bone loss
Coronal 3rd Middle 3rd Apical 3rd
Mann-Whitney U 453.000 458.000 503.000 488.000 495.000
Wilcoxon W 1048.000 923.000 1098.000 1083.000 960.000
Z −0.769 −0.702 −0.100 −0.297 −0.230
Asymp. Sig. 
(2-tailed)
0.442 0.483 0.920 0.767 0.818
a. Grouping variable: Sex
Table 6. 
Comparative analysis of genderwise distribution of No. of bone loss site based on categories.
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Previous literature has also reported that there was no significant sex differ-
ence. Gender is inherently a very complex risk factor that may play a role through 
diverse mechanisms as discussed in earlier sections. Premenopausal women exhibit 
the lower prevalence of periodontitis as compared with men and on contrary, after 
menopause, with a weakening estrogen signal, women may show equal or even 
greater periodontal destruction as compared to age matched men [168]. Wulandari 
et al. reported no difference in periodontal severity between perimenopausal and 
postmenopausal women, however, emphasized the role of the bacterial plaque 
regarding periodontal disease severity in perimenopausal and postmenopausal 
women in a cross-sectional investigation in 63 subjects, aged 45–59 years, in East 
Jakarta [169]. Paramashivaiah et al. examined 104 postmenopausal women, age-
group ranging from 35 to 60 years, and reported radiographic alveolar bone loss 
correlated with clinical indicators including attachment loss. Most females had peri-
odontitis and low serum 17-β estradiol and calcium levels [170]. Lee et al. indicated 
an association between hormone replacement therapy (HRT) and periodontal dis-
ease, after adjusting for various potential confounders for periodontal diseases. The 
authors showed that the HRT+ group was less likely to develop periodontal diseases 
Category of patient No. of 
patients
Median Std. 
deviation
Interquartile range
<=30 years No. of sites with 
horizontal bone loss
11 5.00 4.657 4.00 13.00
No. of sites with 
vertical bone loss
11 4.00 6.496 0.00 8.00
Coronal 3rd 11 5.00 3.828 .00 7.00
Middle 3rd 11 4.00 8.201 0.00 14.00
Apical 3rd 11 0.00 4.771 0.00 2.00
>30 years No. of sites with 
horizontal bone loss
53 10.00 5.375 6.00 14.00
No. of sites with 
vertical bone loss
53 7.00 5.170 4.00 10.00
Coronal 3rd 53 0.00 4.383 0.00 4.00
Middle 3rd 53 13.00 6.739 8.00 18.00
Apical 3rd 53 0.00 4.984 0.00 3.50
Table 7. 
Agewise distribution of No. of bone loss site based on categories.
No. of sites with 
horizontal bone 
loss
No. of sites 
with vertical 
bone loss
Coronal 3rd Middle 3rd Apical 3rd
Mann-Whitney U 187.500 211.000 211.500 159.000 248.000
Wilcoxon W 253.500 277.000 1642.500 225.000 314.000
Z −1.856 −1.437 −1.514 −2.362 −0.881
Asymp. Sig. 
(2-tailed)
0.064 0.151 0.130 0.018* 0.378
a. Grouping variable: Age-groups
Table 8. 
Comparative analysis of agewise distribution of No. of bone loss site based on categories.
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than the HRT- group upon analysis of 45 and 74 years old menopausal women 
[171]. Another study by Pizzo et al. in 91 Italian menopausal women (50 ~ 62 years) 
reported similar periodontal pocket depths between the group who underwent HRT 
Age-groups Total Asymp. Sig. 
(2-sided)
>30 years <=30 years
Total sites 13 >13 Count 42 5 47 0.021*
% within 
age-groups
79.2% 45.5% 73.4%
<=13 Count 11 6 17
% within 
age-groups
20.8% 54.5% 26.6%
Total Count 53 11 64
% within 
age-groups
100.0% 100.0% 100.0%
Risk estimate
Value 95% Confidence interval
Lower Upper
Odds ratio for total sites 13 
(>13/<=13)
4.582 1.176 17.849
For cohort age-groups = > 30 years 1.381 0.959 1.989
For cohort age-groups = <= 30 years 0.301 0.106 0.861
No. of valid cases 64
Table 10. 
Risk estimate of bone loss based on age as a risk determinant.
M F Asymp. Sig. 
(2-sided)
Total sites 13 >13 Count 26 0.559 47 0.559
% within Sex 76.50% 70.00% 73.40%
<=13 Count 8 9 17
% within Sex 23.50% 30.00% 26.60%
Total Count 34 30 64
% within Sex 100.00% 100.00% 100.00%
Risk Estimate
Value 95% Confidence interval
Lower Upper
Odds ratio for total sites 13 
(>13 / <=13)
1.393 0.458 4.237
For cohort SEX = M 1.176 0.668 2.07
For cohort SEX = F 0.844 0.487 1.462
No. of valid cases 64
Table 9. 
Risk estimate of bone loss based on gender as a risk determinant.
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and who did not, but the group without HRT had a higher level of dental plaque 
[172]. López-Marcos et al. [173] studied in 210 Spanish menopausal women aged 
40–58 years that the estrogen patch group showed a reduction in periodontal pocket 
depth. People with a longer menopausal period and lower bone mass more evidently 
witnessed the effects of esterogen deficiency [174, 175]. The authors recommend 
that the studies aimed at a clear delineation of the role of gender as a risk factor 
should rather be more meticulously designed in terms of studying the role of gender 
in differential age-groups, larger study samples, and well-designed investigations as 
females undergo specific periods of hormonal fluctuations according to the stage of 
their reproductive life cycle.
A study was conducted by Wouters et al. in 1989 in 733 randomly selected den-
tate individuals aged 20 years and above using periapical radiographs with inter-
proximal intrabony periodontal defect depth and width of at least 5 and 10 mm, 
respectively, to determine the relationship between the prevalence of interproximal 
periodontal intrabony defect and age. It was reported that the prevalence increased 
with age and was higher in men than in women [168]. However, the significantly 
lower prevalence of interproximal periodontal intrabony defect in women than in 
men does not support the studies of Nielsen et al. [176], in which no significant sex 
differences were reported [177]. The present study findings still need to compare 
with caution as it differed in the X-ray images taken as reference was OPGs of the 
study subjects. So the differences in study settings, design and tools may also be 
responsible for the observed heterogeneity in study results.
A higher incidence of bone loss in adult patients (24–30 years old) is a fact, that 
periodontitis is an age dependent disease the incidence and severity of bone loss and 
attachment loss increase with age (16) as a result of longer exposure to local factors 
as age grows older. The present study revealed a nonsignificantly higher prevalence 
of bone loss among females than males, and the authors attributed these findings to a 
higher prevalence of aggressive periodontitis among females rather than males [178].
Khateeb et al. carried out an investigation in a total of 190 female patients (mean 
age, 22.4 ± 2.46 years) and Patients’ age was found to be a good predictor for alveolar 
bone loss and number of periapical lesions (P ≤ 0.05). [179] Another study from 
China revealed that 40–59-year-old patients with chronic periodontitis had severe 
bone loss. And a lesser degree of alveolar bone loss was seen in males than females 
[179]. Menopause in females and smoking in both genders may have affected the level 
of bone loss. Male smokers experienced a greater degree of bone loss (41.67 ± 5.76%) 
than male non-smokers (32.95 ± 4.31%). A 42.23 ± 6.34% bone loss was found in 
menopausal females versus 31.35 ± 3.62% in non-menopausal females [180].
Bansal M et al. (2015) [181], in a cross-sectional prevalence study among 
hospital-based Indian population, assessed the prevalence of the periodontal dis-
ease. They stated that healthy periodontium was found in 19 (3.9%) subjects with 
the highest percentage in the 15–19 years age-groups and after 44 years no person 
had healthy teeth. Also, advanced stages were more prevalent in older age-groups, 
deep pockets occurring in 87 (17.90%) subjects that increased as the age advanced 
up to 45–54. According to them, males were more affected with moderate and 
severe periodontitis as compared to females. Bokhari et al. (2015) [28], reported 
that subjects aged 40 years and above were four times more likely to have periodon-
titis using Community Periodontal Index (CPI) methods. Marya, CM, et al. (2020) 
[182], in a cross sectional study assessed if there are any gender differences in oral 
health-related quality of life (OHRQoL) among the elderly population of Haryana. 
Genderwise, no significant association was found with different parameters of 
periodontitis. They found a significant association of OHRQoL with the main factor 
causing periodontal problems, that is, mobile teeth and no comparable difference 
was observed in the OHRQoL among males and females. They suggested one needs 
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to target the geriatric population as a whole for planning and implementing public 
oral health strategies.
5.  Clinical relevance of understanding the specific effects of gender  
on periodontal disease
Despite the extensive evidence from the recent past has recognized gender as 
an important factor in the regulation of immune responses, sex differences are still 
very much understudied and poorly understood in scientific research with females 
being under-represented in clinical disease trials. Specific exploration of sex-
specific biomarkers should be considered for both the genders. Studies of multifac-
torial diseases demonstrate differential susceptibilities between genders encounter 
confounding variables, such as lifestyle, socioeconomic status, environmental 
exposures, and genetic polymorphisms. Hence, novel experimental models with 
gender differences shall be developed to understand disease pathogenesis based on 
gender [183, 184].
Effie Ioannidou in 2017 developed the methodological and analytical framework 
with the recognition of sex/gender as important determinants of disease patho-
genesis. The authors aimed to present relevant sex biologic evidence to understand 
the plausibility of the epidemiologic data. In periodontitis pathogenesis, sex 
dimorphism has been implicated in the disease etiology. With the clear distinction 
between sex and gender, gender oral health disparities have been explained by 
socioeconomic factors, cultural attitudes as well as access to preventive and regular 
care. Economic inequality and hardship for women have resulted in limited access 
to oral care in some parts of the world. As a result, gender emerged as a complex 
socioeconomic and behavioral factor influencing oral health outcomes [185].
With the expanding knowledge regarding gender as a risk factor, we must intend 
to perform specific gender-based periodontal research to find better insight into the 
mechanisms of disease pathogenesis and mediators, so that specific gender-based 
tools for periodontal diagnosis, risk assessment, predictive medicine, and disease 
management strategies can be developed to provide optimized periodontal health 
care solutions to our patients.
6. Conclusion
Our current knowledge and understanding of the specific role of gender in the 
context of periodontal health status remain limited and need further elucidation. 
The combined effect of sex-specific genetic architecture and the circulating levels 
of sex steroid hormones may account for variation in risk for chronic periodontitis, 
with men exhibiting greater susceptibility than women. The preliminary case study 
presented here revealed age as a significantly associated factor, with the total num-
ber of bone loss sites and with the bone loss site extended up to a middle third of 
tooth root (moderate to severe periodontitis cases), but could not delineate gender, 
the primary factor being explored as a clear-cut risk factor, owing to the lack of 
statistical strength and study limitations as the small-sized sample, retrospective 
study design. This shall not obviate the need to explore this factor as a cause of 
concern as contemporary models of periodontal pathogenesis; differences in sus-
ceptibility, and progression of destructive periodontal disease are attributed to the 
individual and collective biologic and modifiable risk factors. With this framework 
of information, gender as a risk factor for periodontal disease needs to decipher 
in detail its underlying mechanisms by conducting longitudinal well-controlled, 
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designed, and characterized studies. Such investigations to further explore the 
role of gender in the prevalence, progression, and severity of chronic periodontal 
disease are warranted in the future so that novel strategies for risk assessment, 
disease identification, and individualized therapeutic approaches can be developed 
for optimized patient care based on gender.
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